Global CRO positioned around on-time Phase II/III delivery with notable oncology and complex indication coverage.
Vendor description
Best suited for sponsors that want global coverage with a more focused and private-CRO operating style.
Sponsors prioritising timeline discipline,mid-market fit,and complex therapeutic depth without defaulting to mega-CRO scale.
- Strong time-to-milestone positioning
- Broad therapeutic coverage
- Sponsor loyalty/repeat business messaging
- Public evidence is primarily corporate-site claims
- Scale profile appears below top-tier mega-CROs
Approved customer reviews
Write a reviewNo reviews yet
Be the first customer to share verified experience with this vendor.
Review snapshot
I did not locate a strong public employee-review footprint for PSI CRO in this pass. That is common for smaller or more specialized full-service cro vendors,where staff commentary is often sparse on major public review platforms. Treat the absence of reviews cautiously and place more weight on direct references,case studies,and platform-native reviews once collected.
No consistent public positive themes located
No consistent public negative themes located
Insufficient public evidence
Pricing
$
mid-market
Key facts
| HQ country | Switzerland |
|---|---|
| Geography | Global |
| Service model | Full-service |
| Customer segment | mixed |
| Study phases | Mixed |
| Trial scale | Global studies with strong specialist and private-CRO posture |
| Therapeutic areas | Oncology, Cell and gene therapy, Neurology, Cardiology |
| Last reviewed | 2026-03-28 |
Related vendors
Editorial ranking
See how PSI CRO compares - best Full-service CRO vendors for clinical trials.